Salsola oppositifolia is a type of Herb and its properties as follows :-
Active Compound Qty/100gram Qty/day (Min-Max) T_half (Min-Max) Peak value (Min-Max)       Qty/gm_Ref        Qty/gm_Url            Qty/day_Ref        Qty/day_Url            T_half_Ref        T_half_Url         Peak value_Ref       Peak value_Url     
Salsola oppositifolia is a type of Herb and its properties as follows :-
Enhencer Effect Reference Url
Salsola oppositifolia is a type of Herb and its properties as follows :-
Inhibitor Effect Ref Url
Salsola oppositifolia is a type of Herb and its properties as follows :-
Dietary_product Type Temperature Ref_Temp Url_Temp

Pathway of Dietary Product


Medicine Mechanism Pathway       Reference             URL      
Galantamine hydrobromide same pathway Salsola oppositifolia act as cholisterase inhibitor . Murray, A. (2013). Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy. Curr Neuropharmacol, 11(4), 388–413. http://dx.doi.org/10.2174/1570159X11311040004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744903/
Tacrine same pathway Acetylcholistrase inhibitor Murray A. Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy. Curr nuropharmacol. 2013;11(4):388–413. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744903/
Donepezil same pathway Acetylcholistrase inhibitor Murray, A. (2013). Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy. Curr Neuropharmacol, 11(4), 388–413. http://dx.doi.org/10.2174/1570159X11311040004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744903/
Rivastigmine same pathway Acetylcholistrase inhibitor Murray, A. (2013). Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy. Curr Neuropharmacol, 11(4), 388–413. http://dx.doi.org/10.2174/1570159X11311040004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744903/
Memantine hydrochloride same pathway Acetylcholistrase inhibitor Murray, A. (2013). Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy. Curr Neuropharmacol, 11(4), 388–413. http://dx.doi.org/10.2174/1570159X11311040004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744903/

Dietary Substance Interactions


Medicine Interaction       Reference             URL      

ContraIndication Dietary Substance


Medicine Contraindication       Reference             URL